ESC 365 - When should prolonged antiplatelet regimens be considered?

ESC Professional Premium Access

When should prolonged antiplatelet regimens be considered?

Session: Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration

Topic: Acute Coronary Syndromes

Speaker: Doctor S. Montenegro (Recife, BR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Sergio Tavares Montenegro

Procape, Recife (Brazil)

1 presentation

1 follower

3 more presentations in this session

Antiplatelet monotherapy in acute coronary syndromes: which patients and when

Speaker: Assistant Professor P. Lemos (Sao Paulo, BR)

Is prasugrel preferred over ticagrelor?

Speaker: Professor A. Kastrati (Munich, DE)

Oral anticoagulant therapy with antiplatelet therapy: what is evidence-based practice?

Speaker: Doctor R. Colleran (Dublin 7, IE)

Access the full session

Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration

Speakers: Doctor S. Montenegro, Assistant Professor P. Lemos, Professor A. Kastrati, Doctor R. Colleran

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources